According to the Zhitong Finance App, Peijia Medical-B (09996.HK) announced that the GeminiOne® transcatheter edge repair (“TEER”) system (“GeminiOne®”) independently developed by the company has recently been approved by the China Drug Administration (“State Drug Administration”) of the People's Republic of China (“State Drug Administration”).

According to the Zhitong Finance App, Peijia Medical-B (09996.HK) announced that the GeminiOne® transcatheter edge repair (“TEER”) system (“GeminiOne®”) independently developed by the company has recently been approved by the China Drug Administration (“State Drug Administration”) of the People's Republic of China (“State Drug Administration”).